Company
Headquarters: Tokyo, Japan
Employees: 431
CEO: Mr. Yukio Hoshi
¥16.25 Billion
JPY as of July 1, 2024
US$100.6 Million
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $75.67 B |
| Cencora, Inc. | $43.82 B |
| Cardinal Health, Inc. | $23.31 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $8.79 B |
| Sinopharm Group Co. Ltd | $8.37 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Hoshi Iryo-Sanki Co., Ltd. manufactures and sells pharmaceutical medical oxygen and nitrous oxides in Japan. It also plans, manufactures, sells, maintains, inspects, and repairs medical instruments equipment for medical gas supply facilities, and care and welfare equipment, as well as provides home oxygen therapy support services. In addition, the company operates nursing homes and day care facilities. Hoshi Iryo-Sanki Co., Ltd. was founded in 1960 and is headquartered in Tokyo, Japan.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Hoshi Iryo-Sanki Co. Ltd has the following listings and related stock indices.
Stock: JPX: 7634 wb_incandescent